Navigation Links
Artificial disc brings increased mobility and rapid recovery to patients suffering chronic neck pain in the Midwest
Date:11/15/2012

KANSAS CITY, Mo., Nov. 15, 2012 /PRNewswire-USNewswire/ -- For many years cervical fusion was the only surgical option for patients suffering from chronic neck pain or single cervical disc degeneration.  The recent creation and approval of artificial discs have offered patients a new treatment option which allows greater mobility and range of motion and dramatically improved recovery times.  However, these initial artificial discs utilized hardware such as screws and pins.

On Nov. 13, 2012, H. Dennis Mollman, M.D., Ph.D. of Saint Luke's Neuroscience Institute of Kansas City, performed the first Bryan Disc surgery in Missouri, Kansas and Iowa, offering patients in the Midwest a new option for dealing with chronic neck pain. The Bryan Disc is an artificial cervical disc replacement which requires no hardware and can simply slide in and replace the patient's damaged natural disc.

"In the past cervical fusion was the standard treatment option," said Dr. Mollman, "Fusing the bones together limited range of motion and generally required a three month recovery as we waited for the bones to grow together.  The Bryan Disc allows patients to retain or regain range of motion and most are back to their normal activities within two weeks, a vastly improved recovery time."

As opposed to a lengthy cervical fusion surgery of four to six hours, the Bryan Disc surgery takes approximately 45 minutes. Patients generally leave the hospital the next day.  According to Dr. Mollman, these factors, coupled with the fact the Bryan Disc more closely resembles the patient's own natural disc, make it an appealing treatment option for patients considering cervical fusion or disc replacement.

More information about Dr. Mollman and the Bryan Disc can be found at https://www.saintlukeshealthsystem.org/docoffice/saint-luke-s-neurosurgery-clinic and http://wwwp.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=1244730407543&lang=en_US respectively.

About the Saint Luke's Neuroscience Institute

Saint Luke's Neuroscience Institute, a member of Saint Luke's Health System, is a global leader in utilizing both drug and mechanical interventions to block and reverse the permanent and debilitating effects of acute strokes. Its legacy of innovation began in 1993 when doctors performed one of the world's first intra-arterial stroke reversal procedures. Since then, Saint Luke's specialists have continued to pioneer new stroke therapies and reverse stroke's debilitating effects for thousands of patients, and is one of the world's most experienced and prolific leaders in the use of tPA, a clot-busting medication for treatment of acute ischemic stroke.   SLNI, headquartered in Kansas City,  brings together a team of the country's most accomplished neurologists to provide a comprehensive treatment center for the most complex neurological issues.


'/>"/>
SOURCE Saint Luke's Health System
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 1st SynCardia Total Artificial Heart Patient Discharged from Ankara University in Turkey
2. Study Results of Artificial Disc Recipients Show Significant Improvement Compared to Pre-Surgery Condition
3. Global Artificial Implants Industry
4. Global Artificial Tears Industry
5. SynCardia Total Artificial Heart Patient Featured in U.S. News & World Reports "Best Hospitals" Issue
6. Global Artificial Organs Industry
7. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
8. 50% of U.S. News & World Reports "Best Hospitals" for Cardiology & Heart Surgery Making the SynCardia Total Artificial Heart Part of Their Toolbox
9. 1st SynCardia Total Artificial Heart Implant Performed in New England
10. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
11. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Brain Cancer ... treatment method at West Cancer Center . ... fields to inhibit cancer cell replication causing death of ... than a decade to show a significant extension in ... (GBM) patients. Currently, West Cancer Center is the only ...
(Date:2/11/2016)... , Feb. 11, 2016  AbbVie, a ... AbbVie Rheumatology Scholarship, designed to provide financial support ... as they pursue higher education goals. Fifteen scholars ... the 2016-2017 school year. The AbbVie Rheumatology Scholarship ... Haas , vice president, corporate social responsibility, brand ...
(Date:2/11/2016)... 11, 2016 PLAD, Inc. (OTC Pink: PLAD) is ... sales exceeding company targets, are adding key personnel to ... from the United States Patent and Trademark Office for ... Executive Officer of PLAD, Inc.  In January, PLAD established ... with two new customers, Cumberland Goodwill EMS ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western ... (AOA) Match Program Tuesday, February 9, taking one of the final steps in ... medical education positions across the country. Of the 103 student-doctors who comprise the ...
(Date:2/11/2016)... ... 12, 2016 , ... The Journal of Pain Research has seen ... SJR uses data taken from the Scopus database (Elsevier B.V.) and is a measure ... by the journal over a three year period and also the importance of the ...
(Date:2/11/2016)... ... ... Hall Integrative Health and Chiropractic, PC which focuses on ... in March. All seven practices are set to start accepting patients in March ... According to this 2011 CNN article it is possible: http://www.cnn.com/2011/HEALTH/01/28/reverse.diabetes/ . Current ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans ... Catholic health care system that’s partnering with Intel on value-based health benefits program ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
Breaking Medicine News(10 mins):